IL4, interleukin 4, 3565

N. diseases: 996; N. variants: 23
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.070 AlteredExpression disease BEFREE Herein, we report that human MM RPMI 8226 cell line shows a pronounced chemoattractant activity for monocytes and also expresses enhanced levels of the leukocyte chemotactic cytokines CXCL12, CCL5, MIP-1β, and CXCL10 in association with elevated levels of both key immunoregulatory interleukins such as IL-4 and IL-10. 28702457 2017
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.070 Biomarker disease BEFREE We compared FISH results with and without plasma cell purification for three sample preparation methods: direct harvest, 24-h culture, and 96-h culture with interleukin-4 in five newly diagnosed MM patients. 22672327 2012
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.070 Biomarker disease BEFREE In this study, we show that MM cell lines that are optimally triggered via CD40 and/or IL-4 demonstrate abnormal decoupling of IL-4 signal transduction from CD40. 16453006 2006
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.070 Biomarker disease BEFREE In B cell lines and flowsorted CD38++/CD19-/CD56++ myeloma plasma cells (N = 14) the c-maf/GAPDH and IL-4/GAPDH ratios were determined simultaneously using real time RT-PCR. 14692531 2003
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.070 AlteredExpression disease BEFREE Serum levels of interleukin-4 were tested in the patient with multiple myeloma and the family member with highest Ig production and found to be normal. 8047841 1994
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.070 Biomarker disease BEFREE To examine the resulting composite S mu-S epsilon junctions of human lymphoid cells, we have used a polymerase chain reaction strategy to clone the switch regions of the human myeloma U266 and of two IgE-producing human cell lines generated by treatment of lymphocytes with EBV plus IL-4. 1321850 1992
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.070 Biomarker disease BEFREE Deregulation of the expression of these interleukins was shown to be responsible for various diseases, such as i) IL-4 vs. immediate type hypersensitivity and ii) IL-6 vs. autoimmunity and multiple myelomas. 8691054 1989